GLI1 and acute myeloid leukemia: We could recently show that expression of HH pathway transcription factors GLI1 and GLI2 represents a negative prognostic marker for acute myeloid leukemia and that targeted inhibition of GLI1/2 mediates anti-leukemic effects in vitro and in vivo [6].